MannKind develops dry powder inhaler for pulmonary hypertension treatment
Go back to MannKind develops dry powder inhaler for pulmonary hypertension treatment| Mannkind Corporation (NASDAQ: MNKD) | Delayed: 3.85 +0.01 (0.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.84 | 52 Week High | $2.51 | |||
| Open | $3.86 | 52 Week Low | $0.41 | |||
| Day High | $3.92 | P/E | N/A | |||
| Day Low | $3.84 | EPS | $-0.64 | |||
| Volume | 3,052,254 | |||||
| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 511.72 -3.78 (0.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $515.50 | 52 Week High | $164.04 | |||
| Open | $510.44 | 52 Week Low | $97.52 | |||
| Day High | $521.43 | P/E | 93.55 | |||
| Day Low | $506.01 | EPS | $5.47 | |||
| Volume | 314,978 | |||||
